You are here

P&T News

October 24

Therapeutic protein aids antibacterial drug treatment
Nonlive recombinant vaccine reduces postherpetic neuralgia in phase 3 studies

October 21

Controversy still surrounds muscular dystrophy drug
Cost of Iclusig jumped four times this year
U.S. hospitals borrow idea from South Africa
Monoclonal antibody bests chemotherapy
ALKS 5461 is effective as adjunctive therapy

October 20

Device bypasses expensive ‘clean rooms’
Chlamydia, gonorrhea, and syphilis take double-digit jumps
First new initial treatment of STS in more than 40 years
Desmopressin nasal spray gets ‘thumbs up,’ with reservations

October 19

Treatment is limited to patients with specific EGFR mutations
Insoluble compound traps potassium ions
Therapy meets primary endpoint in phase 3 trial